Comparing the Performance of the Optical Glucose Assay Based on Glucose Binding Protein with High-Performance Anion-Exchange Chromatography with Pulsed Electrochemical Detection: Efforts to Design a Low-Cost Point-of-Care Glucose Sensor (original) (raw)
Related papers
Fluorescence-based glucose sensors
Biosensors and Bioelectronics, 2005
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects with diabetes mellitus. Problems with existing devices based on electrochemistry have encouraged alternative approaches to glucose sensing in recent years, and those based on fluorescence intensity and lifetime have special advantages, including sensitivity and the potential for non-invasive measurement when nearinfrared light is used. Several receptors have been employed to detect glucose in fluorescence sensors, and these include the lectin concanavalin A (Con A), enzymes such as glucose oxidase, glucose dehydrogenase and hexokinase/glucokinase, bacterial glucose-binding protein, and boronic acid derivatives (which bind the diols of sugars). Techniques include measuring changes in fluorescence resonance energy transfer (FRET) between a fluorescent donor and an acceptor either within a protein which undergoes glucose-induced changes in conformation or because of competitive displacement; measurement of glucose-induced changes in intrinsic fluorescence of enzymes (e.g. due to tryptophan residues in hexokinase) or extrinsic fluorophores (e.g. using environmentally sensitive fluorophores to signal protein conformation). Noninvasive glucose monitoring can be accomplished by measurement of cell autofluorescence due to NAD(P)H, and fluorescent markers of mitochondrial metabolism can signal changes in extracellular glucose concentration. Here we review the principles of operation, context and current status of the various approaches to fluorescence-based glucose sensing.
Analytica Chimica Acta, 1993
Optical fiber biosensors based on fluorescence assays have several distinct advantages when measuring biological analytes such as metabolites, cofactors, toxins, etc. Not only are optical signals immune to electronic interferences, but the polychromatic nature of most fluorochemical assays provides more potentially useful data about the system being studied. One of the most common difficulties normally encountered with optical biosensors is the inability to routinely recalibrate the optical and electronic components of the system throughout the life of the sensor. With this in mind, an optical fiber biosensor system for glucose has been constructed along with the peripheral electronic instrumentation. The biochemical assay is based on an homogeneous singlet/singlet energy transfer affinity assay. The sensor probe indirectly measures glucose concentrations from the level of fluorescence quenching caused by the homogeneous competition assay between TRITC labeled concanavalin A (receptor) and FITC labeled Dextran (ligand). The FITC signal is used as an indicator for glucose concentrations and the TRITC signal is used for internal calibration. Chemical derivatization procedures using succinic anhydride were developed to prevent aggregation of the receptor protein in solution, and the TRITC/ConA ratios were optimized to achieve the best sensor performance. Using this sensor system, the FITC-Dextran detection limit was 0.05 bg/ml and glucose concentrations up to 1600 mg/dl could be detected with a time response of approximately 10 min.
Electroanalysis, 2020
This work describes the development of a novel method for glucose determination exploiting a photoelectrochemicalassisted batch injection analysis cell designed and constructed with the aid of 3D printer technology. The PEC-BIA cell was coupled to a LED lamp in order to control the incidence of light on the Cu 2 O/Ni(OH) 2 /FTO photoelectroactive platform. The electrochemical characteristics of Cu 2 O/Ni(OH) 2 /FTO photoelectroactive platform were evaluated by cyclic voltammetry, amperometry, and electrochemical impedance spectroscopy. The PEC-BIA cell presented linear response range, limit of detection based on a signal-to-noise ratio of three, and sensitivity of 1-1000 μmol L-1 , 0.76 µmol L-1 and 0.578 µA L µmol-1 , respectively. The PEC-BIA method presented a mean value of the recovery values of 97.0 % to 102.0 % when it was applied to glucose determination in artificial blood plasma samples which indicates the promising performance of the proposed system to determine glucose.
Analytical Biochemistry, 2010
We synthesized mutants of glucose/galactose-binding protein (GBP), labeled with the environmentally sensitive fluorophore Badan, with the aim of producing a fluorescence-based glucose sensing system with an operating range compatible with continuous glucose monitoring in patients with diabetes mellitus. From five mutants tested, the triple mutant H152C/A213R/L238S-Badan showed a large (200%) maximal increase in fluorescence intensity on the addition of glucose, with a binding constant (K d ) of 11 mM, an operating range of approximately 1-100 mM, and similar responses in buffer and serum. The mean fluorescence lifetime of this mutant also increased by 70% on the addition of glucose. We conclude that the GBP mutant H152C/A213R/L238S, when labeled with Badan, is suitable for development as a robust sensor for in vivo glucose monitoring in diabetes.
Fluorescence Glucose Detection: Advances Toward the Ideal In Vivo Biosensor
Journal of Fluorescence, 2000
The importance of glucose monitoring for in vivo as well as for ex vivo applications has driven a vast number of scientific groups to pursue the development of an advanced glucose sensor. Such a sensor must be robust, versatile, and capable of the long-term, accurate and reproducible detection of glucose levels in various testing media. Among the different configurations and signal transduction mechanisms used, fluorescence-based glucose sensors constitute a growing class of glucose sensors represented by an increasing number of significant contributions to the field over the last few years. This manuscript reviews the progress in the development of fluorescence based glucose sensors resulting from the advances in the design of new receptor systems for glucose recognition and the utilization of new fluorescence transduction schemes.
Trace Glucose Electrode for Clinical, Food and Environmental Determinations
1979
A very sensitive method has been devised for the determination of glucose using electrochemical sensors. The differential device includes a glucose electrode, consisting of a platinum disk covered by a Beta-D-glucose oxidase collagen membrane, and a compensating electrode mounted with a non-enzymatic collagen membrane. Current outputs of both electrodes are substracted and differentiated giving steady-state and dynamic responses proportional to glucose concentration in the 100 nM - 2mM range. The glucose sensor has been successfully tested in clinical (human whole blood, plasma or serum and human seminal plasma), food (fruit, wines, preserved food) and environmental analysis (polluted river, whey) illustrating the high selectivity and versatility of the device.
Journal of Diabetes Science and Technology, 2013
Background: Our motivation for this study was to develop a noninvasive glucose sensor for low birth weight neonates. We hypothesized that the underdeveloped skin of neonates will allow for the diffusion of glucose to the surface where it can be sampled noninvasively. On further study, we found that measurable amounts of glucose can also be collected on the skin of adults. Method: Cellulose acetate dialysis membrane was used as surrogate for preterm neonatal skin. Glucose on the surface was collected by saline-moistened swabs and analyzed with glucose-binding protein (GBP). The saline-moistened swab was also tested in the neonatal intensive care unit. Saline was directly applied on adult skin and collected for analysis with two methods: GBP and high-performance anion-exchange chromatography (HPAEC). Results: The amount of glucose on the membrane surface was found (1) to accumulate with time but gradually level off, (2) to be proportional to the swab dwell time, and (3) the concentrat...
Glucose sensors: a review of current and emerging technology
Diabetic Medicine, 2009
Glucose monitoring technology has been used in the management of diabetes for three decades. Traditional devices use enzymatic methods to measure glucose concentration and provide point sample information. More recently continuous glucose monitoring devices have become available providing more detailed data on glucose excursions. In future applications the continuous glucose sensor may become a critical component of the closed loop insulin delivery system and, as such, must be selective, rapid, predictable and acceptable for continuous patient use. Many potential sensing modalities are being pursued including optical and transdermal techniques. This review aims to summarize existing technology, the methods for assessing glucose sensing devices and provide an overview of emergent sensing modalities.
Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium
Diabetes Technology & Therapeutics, 2004
There are three main issues in non-invasive (NI) glucose measurements: namely, specificity, compartmentalization of glucose values, and calibration. There has been progress in the use of near-infrared and mid-infrared spectroscopy. Recently new glucose measurement methods have been developed, exploiting the effect of glucose on erythrocyte scattering, new photoacoustic phenomenon, optical coherence tomography, thermo-optical studies on human skin, Raman spectroscopy studies, fluorescence measurements, and use of photonic crystals. In addition to optical methods, in vivo electrical impedance results have been reported. Some of these methods measure intrinsic properties of glucose; others deal with its effect on tissue or blood properties. Recent studies on skin from individuals with diabetes and its response to stimuli, skin thermo-optical response, peripheral blood flow, and red blood cell rheology in diabetes shed new light on physical and physiological changes resulting from the disease that can affect NI glucose measurements. There have been advances in understanding compartmentalization of glucose values by targeting certain regions of human tissue. Calibration of NI measurements and devices is still an open question. More studies are needed to understand the specific glucose signals and signals that are due to the effect of glucose on blood and tissue properties. These studies should be performed under normal physiological conditions and in the presence of other co-morbidities.